HALE PATH PACKAGING LTD

Company number 13600651 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

Financial Health Assessment: HALE PATH PACKAGING LTD

1. Financial Health Score: B- The patient is experiencing a rapid growth spurt but is showing signs of "liquidity anemia." While the overall body mass (net assets) is increasing at an impressive rate, the circulatory system (working capital) is running a deficit. The company is building long-term strength but is vulnerable to short-term cash flow shocks.

2. Key Vital Signs * Net Assets (The Heartbeat): £25,960 – This represents the company's total equity, and it is beating stronger than ever. Up from just £10,041 in 2024 and £411 in 2023, this rapid accumulation of wealth indicates a business that is fundamentally growing its value. * Working Capital / Net Current Assets (Blood Pressure): -£1,048 – This is a symptom of distress. Current assets (£20,951) are slightly outweighed by current liabilities (£21,999). Just like low blood pressure, this means the company doesn't have quite enough immediate fluid (cash or near-cash assets) to comfortably meet its immediate obligations. * Fixed Assets (Bone Density): £27,008 – The company has significantly invested in long-term assets, tripling this figure from £9,080 in the prior year. For a retail packaging company, this likely represents equipment, machinery, or potentially intellectual property/web infrastructure required for expansion. * Total Liabilities (Cholesterol): £21,999 – The company's debts are almost entirely short-term (due within one year). While the overall debt level is manageable relative to total assets, having all debt clustered in the short term creates a blockage in cash flow.

3. Diagnosis Rapid Growth with Liquidity Anemia: HALE PATH PACKAGING LTD is a young, expanding micro-entity that is successfully generating profit and reinvesting it into the business. However, the financial data reveals a classic growing pain: the business is "asset rich but cash poor." The significant jump in fixed assets suggests the directors have ploughed available cash into long-term equipment or resources. Because of this, the company has slipped into negative working capital.

While net assets are healthy, the fact that current liabilities exceed current assets means that if creditors demanded payment tomorrow, the company would not be able to settle its debts using only its short-term assets. The zero-employee headcount suggests a highly lean, likely director-operated or fully outsourced operation, which keeps overheads low but means the business model relies heavily on the directors' ongoing labour without drawing a formal payroll.

4. Recommendations To improve financial wellness and stabilize the circulatory system, the following prescriptions are advised:

  • Improve Cash Circulation (Working Capital): The priority is to close the £1,048 working capital deficit. This can be done by accelerating cash collection from customers or delaying cash outflows to suppliers (negotiating longer payment terms).
  • Short-Term Financial Transfusion: Consider a small, flexible working capital facility (like an overdraft or a short-term director's loan) to provide a buffer for day-to-day operations. This prevents the business from having to delay creditor payments, which could damage supplier relationships.
  • Balance Long-Term Investments: Before making further investments in fixed assets, ensure that enough cash is being retained in the business to cover day-to-day operating expenses. Don't let the pursuit of long-term growth starve the short-term circulatory system.
  • Monitor the Pulse Regularly: Because the margins are tight on the balance sheet, the directors should review cash flow forecasts weekly rather than just at year-end. Early detection of a cash squeeze is vital for a micro-entity.

Perspective: Financial Health Diagnostician · Model: glm-5.1 · Generated 4 August 2026